Unraveling a history of overlap: A phenotypic comparison of RBCK1‐related disease and glycogen storage disease type IV
Open Access
- 4 March 2024
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (7) , e63574
Abstract
RBCK1‐related disease is a rare, multisystemic disorder for which our current understanding of the natural history is limited. A number of individuals initially carried clinical diagnoses of glycogen storage disease IV (GSD IV), but were later found to harbor RBCK1 pathogenic variants, demonstrating challenges of correctly diagnosing RBCK1‐related disease. This study carried out a phenotypic comparison between RBCK1‐related disease and GSD IV to identify features that clinically differentiate these diagnoses. Literature review and retrospective chart review identified 25 individuals with RBCK1‐related disease and 36 with the neuromuscular subtype of GSD IV. Clinical features were evaluated to assess for statistically significant differences between the conditions. At a system level, any cardiac, autoinflammation, immunodeficiency, growth, or dermatologic involvement were suggestive of RBCK1, whereas any respiratory involvement suggested GSD IV. Several features warrant further exploration as predictors of RBCK1, such as generalized weakness, heart transplant, and recurrent infections, among others. Distinguishing RBCK1‐related disease will facilitate correct diagnoses and pave the way for accurately identifying affected individuals, as well as for developing management recommendations, treatment, and an enhanced understanding of the natural history. This knowledge may also inform which individuals thought to have GSD IV should undergo reevaluation for RBCK1.Keywords
This publication has 33 references indexed in Scilit:
- RBCK1‐related disease: A rare multisystem disorder with polyglucosan storage, auto‐inflammation, recurrent infections, skeletal, and cardiac myopathy—Four additional patients and a review of the current literatureJournal of Inherited Metabolic Disease, 2020
- Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?2018
- Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV2018
- Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype–phenotype spectrumJournal of Neurology, 2017
- Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1Annals of Neurology, 2013
- Non‐lethal neonatal neuromuscular variant of glycogenosis type IV with novel GBE1 mutationsMuscle & Nerve, 2009
- Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 geneJournal of Inherited Metabolic Disease, 2009
- Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 geneActa Neuropathologica, 2008
- Prenatal diagnosis of glycogen storage disease type IVPrenatal Diagnosis, 2006
- Non-lethal congenital hypotonia due to glycogen storage disease type IVAmerican Journal of Medical Genetics Part A, 2006